The Riskalyze Report: Advisors Buy the Small Cap Rally

At the request of so many investment advisors, my friends at Riskalyze share the big trends in the assets going into and coming out of advisor portfolios every week. The underlying data is aggregated from hundreds of thousands of client accounts across the $44 billion and counting that advisors manage on the Riskalyze platform*. I…

Yeah I said it…

Which should I allocate to? a) the parabolic biotech bubble b) an illiquid startup c) negative-interest sovereign bonds Thanks — Downtown Josh Brown (@ReformedBroker) March 23, 2015